Drugs Made In America Acquisition (DMIIR) Change in Account Payables (2025)
Drugs Made In America Acquisition (DMIIR) posted quarterly Change in Account Payables of $94767.0 for Q4 2025.
Analysis
Drugs Made In America Acquisition (DMIIR) Change in Account Payables (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Change in Account Payables for 1 consecutive years, with $94767.0 the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | - |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | - |
| 4 | Armada Acquisition | 665.67 Mn | 665.62 Mn | - | - |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | 21,444.00 |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | 34,416.00 |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | - |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | - |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | - |